(Q36673729)
Statements
The efficacy versus toxicity profile of combination virotherapy and TLR immunotherapy highlights the danger of administering TLR agonists to oncolytic virus-treated mice (English)
Diana M Rommelfanger
Rosa M Diaz
Elizabeth Ilett
Jill M Thompson
Timothy J Kottke
1 reference
1 reference
1 reference